[HTML][HTML] CDK inhibitors in cancer therapy, an overview of recent development

M Zhang, L Zhang, R Hei, X Li, H Cai… - American journal of …, 2021 - ncbi.nlm.nih.gov
Dysregulated cell division, which leads to aberrant cell proliferation, is one of the key
hallmarks of cancer. Therefore, therapeutic targets that block cell division would be effective …

Chemistry and biology of multicomponent reactions

A Domling, W Wang, K Wang - Chemical reviews, 2012 - ACS Publications
Multicomponent reactions (MCRs) are one-pot reactions employing more than two starting
materials, for example, 3, 4,..., 7, where most of the atoms of the starting materials are …

Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors

M Peyressatre, C Prével, M Pellerano, MC Morris - Cancers, 2015 - mdpi.com
Cyclin-dependent kinases (CDK/Cyclins) form a family of heterodimeric kinases that play
central roles in regulation of cell cycle progression, transcription and other major biological …

Marine natural products

JW Blunt, BR Copp, WP Hu, MHG Munro… - Natural product …, 2009 - pubs.rsc.org
Covering: 2007. Previous review: Nat. Prod. Rep., 2008, 25, 35This review covers the
literature published in 2007 for marine natural products, with 948 citations (627 for the …

CDK9 inhibitors in acute myeloid leukemia

S Boffo, A Damato, L Alfano, A Giordano - Journal of Experimental & …, 2018 - Springer
Current treatment for acute myeloid leukemia (AML) is less than optimal, but increased
understanding of disease pathobiology and genomics has led to clinical investigation of …

Variolins and related alkaloids

SR Walker, EJ Carter, BC Huff, JC Morris - Chemical reviews, 2009 - ACS Publications
The phosphorylation of proteins on serine, threonine, and tyrosine residues by the 518
protein kinases encoded in the human genome constitutes one of the major mechanisms …

Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology

S Wang, PM Fischer - Trends in pharmacological sciences, 2008 - cell.com
Unlike other CDKs, CDK9 does not regulate the cell cycle but promotes RNA synthesis in
genetic programmes for cell growth, differentiation and viral pathogenesis. It is becoming …

Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update

T Wu, Z Qin, Y Tian, J Wang, C Xu, Z Li… - Journal of medicinal …, 2020 - ACS Publications
Cyclin-dependent kinase 9 (CDK9), which regulates transcriptional elongation, is an
attractive therapeutic target for many cancers, especially for cancers driven by transcriptional …

Cyclin dependent kinase 9 inhibitors for cancer therapy: miniperspective

YA Sonawane, MA Taylor, JV Napoleon… - Journal of medicinal …, 2016 - ACS Publications
Cyclin dependent kinase (CDK) inhibitors have been the topic of intense research for nearly
2 decades due to their widely varied and critical functions within the cell. Recently CDK9 has …

[HTML][HTML] An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers

TA Chohan, A Qayyum, K Rehman, M Tariq… - Biomedicine & …, 2018 - Elsevier
Cancer denotes a pathological manifestation that is characterized by hyperproliferation of
cells. It has anticipated that a better understanding of disease pathogenesis and the role of …